115563
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
双氯芬酸钠使用与卵巢储备功能减退女性 IVF 过程中因提前排卵导致周期取消减少的关联：一项回顾性队列研究
Authors Song JY, Ma YJ , Cao XL, Sun ZG
Received 17 October 2025
Accepted for publication 11 January 2026
Published 14 January 2026 Volume 2026:20 575150
DOI https://doi.org/10.2147/DDDT.S575150
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Solomon Tadesse Zeleke
Jing-Yan Song,1,* Ying-Jie Ma,2,* Xian-Ling Cao,2,3 Zhen-Gao Sun1,2
1The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 2Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 3Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
*These authors contributed equally to this work
Correspondence: Xian-Ling Cao, Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 42 Wenhua West Road, Lixia District, Jinan, Shandong, People’s Republic of China, Email caoxianlingling@163.com Zhen-Gao Sun, Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 42 Wenhua West Road, Lixia District, Jinan, Shandong, People’s Republic of China, Email sunzhengao77@126.com
Purpose: To evaluate whether diclofenac sodium administration reduces premature ovulation and improves in vitro fertilization (IVF) outcomes in patients with diminished ovarian reserve (DOR).
Patients and Methods: Retrospective cohort study conducted at a single academic reproductive center from January 2022 to March 2025. We included women with DOR (anti-Müllerian hormone [AMH] < 1.1 ng/mL, antral follicle count [AFC] < 5) undergoing autologous IVF cycles with single dominant follicle development. A total of 1164 cycles from 616 patients were analyzed, comparing 382 cycles with diclofenac sodium 75mg daily from trigger day to oocyte retrieval versus 782 cycles without treatment. The primary endpoint was cycle cancellation due to premature ovulation. Secondary endpoints included oocyte retrieval success, fertilization rates, embryo outcomes, and clinical pregnancy rates. Generalized estimating equation (GEE) models with multivariable adjustment were used to account for correlation between multiple cycles from the same patient. A sensitivity analysis restricted to first cycles per patient (n=616) was performed using logistic regression to validate primary findings.
Results: Diclofenac sodium significantly reduced cycle cancellation due to premature ovulation (7.3% vs 19.8%, adjusted odds ratio [OR] 0.39, 95% confidence interval [CI] 0.21– 0.73, P=0.003) and decreased the proportion of cycles with no oocytes retrieved (21.8% vs 27.1%, adjusted OR 0.54, 95% CI 0.34– 0.84, P=0.007). Normal fertilization rates were higher in the diclofenac sodium group (77.5% vs 69.8%, P=0.041), though this lost significance after adjustment (P=0.184). The proportion of cycles without viable embryos was comparable between groups (42.3% vs 41.8%, P=0.727). Among limited fresh embryo transfers (n=124), clinical pregnancy (19.2% vs 11.2%, P=0.847) and live birth rates (15.4% vs 8.2%, P=0.948) were similar. The sensitivity analysis using first cycles per patient (n=616) confirmed these findings, showing a 47% reduction in premature ovulation odds with diclofenac sodium (adjusted OR 0.53, 95% CI 0.29– 0.94, P=0.031).
Conclusion: Diclofenac sodium is associated with reduced premature ovulation and improved oocyte retrieval success in DOR patients, though embryonic and pregnancy outcomes remain similar. These observational findings require validation through prospective randomized controlled trials with adequate power to assess cumulative reproductive outcomes.
Keywords: diclofenac sodium, premature ovulation, in vitro fertilization, diminished ovarian reserve, oocyte retrieval
1The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 2Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 3Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
*These authors contributed equally to this work
Correspondence: Xian-Ling Cao, Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 42 Wenhua West Road, Lixia District, Jinan, Shandong, People’s Republic of China, Email caoxianlingling@163.com Zhen-Gao Sun, Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 42 Wenhua West Road, Lixia District, Jinan, Shandong, People’s Republic of China, Email sunzhengao77@126.com
Purpose: To evaluate whether diclofenac sodium administration reduces premature ovulation and improves in vitro fertilization (IVF) outcomes in patients with diminished ovarian reserve (DOR).
Patients and Methods: Retrospective cohort study conducted at a single academic reproductive center from January 2022 to March 2025. We included women with DOR (anti-Müllerian hormone [AMH] < 1.1 ng/mL, antral follicle count [AFC] < 5) undergoing autologous IVF cycles with single dominant follicle development. A total of 1164 cycles from 616 patients were analyzed, comparing 382 cycles with diclofenac sodium 75mg daily from trigger day to oocyte retrieval versus 782 cycles without treatment. The primary endpoint was cycle cancellation due to premature ovulation. Secondary endpoints included oocyte retrieval success, fertilization rates, embryo outcomes, and clinical pregnancy rates. Generalized estimating equation (GEE) models with multivariable adjustment were used to account for correlation between multiple cycles from the same patient. A sensitivity analysis restricted to first cycles per patient (n=616) was performed using logistic regression to validate primary findings.
Results: Diclofenac sodium significantly reduced cycle cancellation due to premature ovulation (7.3% vs 19.8%, adjusted odds ratio [OR] 0.39, 95% confidence interval [CI] 0.21– 0.73, P=0.003) and decreased the proportion of cycles with no oocytes retrieved (21.8% vs 27.1%, adjusted OR 0.54, 95% CI 0.34– 0.84, P=0.007). Normal fertilization rates were higher in the diclofenac sodium group (77.5% vs 69.8%, P=0.041), though this lost significance after adjustment (P=0.184). The proportion of cycles without viable embryos was comparable between groups (42.3% vs 41.8%, P=0.727). Among limited fresh embryo transfers (n=124), clinical pregnancy (19.2% vs 11.2%, P=0.847) and live birth rates (15.4% vs 8.2%, P=0.948) were similar. The sensitivity analysis using first cycles per patient (n=616) confirmed these findings, showing a 47% reduction in premature ovulation odds with diclofenac sodium (adjusted OR 0.53, 95% CI 0.29– 0.94, P=0.031).
Conclusion: Diclofenac sodium is associated with reduced premature ovulation and improved oocyte retrieval success in DOR patients, though embryonic and pregnancy outcomes remain similar. These observational findings require validation through prospective randomized controlled trials with adequate power to assess cumulative reproductive outcomes.
Keywords: diclofenac sodium, premature ovulation, in vitro fertilization, diminished ovarian reserve, oocyte retrieval